1. Introduction {#sec0005}
===============

Respiratory viral pathogens from several different families are a major source of morbidity and mortality worldwide. While infection of the upper respiratory tract is common and results in subclinical or mild disease, infection of the lungs can result in severe, potentially lethal diseases, including viral pneumonia, acute respiratory distress syndrome (ARDS), and severe acute respiratory syndrome (SARS). These severe diseases can result from infection by currently circulating viruses, including influenza viruses and respiratory syncytial virus (RSV), or by new viruses that emerge in the human population from animal reservoirs, such as new strains of influenza A virus (IAV) and SARS-associated coronavirus (SARS-CoV). Murine models have been invaluable in the identification of virus and host determinants of disease pathogenesis during respiratory viral infections. While these models provide a complex view of host-pathogen interactions, there is a critical need to have physiologically relevant *in vitro* models that can be used to delineate cell type-specific mechanisms that contribute to disease pathogenesis in the lung. The goal of this study was to develop such an *in vitro* model, from which data can be correlated to well-established *in vivo* models of respiratory viral pathogenesis.

The alveolar epithelium is a critical target for severe respiratory virus infections. The extensive surface area of the alveolar epithelium is composed of two morphologically and functionally distinct cell types. Type I alveolar (ATI) cells, which cover 95% of the surface area of the epithelium, are large thin cells that function in gas and ion exchange and fluid transport ([@bib0310]). The type II alveolar (ATII) cells produce pulmonary surfactant that is required to prevent alveolar collapse and proteins that participate in innate defense of the lung ([@bib0150]). As the dividing cells of the alveolar epithelium, ATII cells serve as progenitors to repair damaged epithelium. Infection of ATI or ATII alveolar epithelial cells of the distal lung has been detected in fatal cases of avian (H5N1) and 2009 pandemic (pH1N1) IAV, RSV, and SARS-CoV ([@bib0095], [@bib0200], [@bib0255], [@bib0250], [@bib0290]). Infection of alveolar epithelial cells is also associated with severe disease in murine models of respiratory viral infections, including mouse-adapted IAV and SARS-CoV ([@bib0020], [@bib0090], [@bib0235]). Viral infection of these physiologically critical cell types causes direct damage to the alveolar epithelium and also immune-mediated pathology, both of which will impair respiration and/or lead to lung collapse due to impaired surfactant production. Alveolar epithelial cells produce inflammatory cytokines and chemokines in response to viral infection and thereby may elicit responses that contribute to both viral clearance and immune-mediated pathology.

Primary cultures of differentiated alveolar epithelial cells are a valuable model to study virus--host interactions in physiologically relevant cell types *in vitro*. ATII cells can be isolated from murine lungs and cultured to maintain an ATII cell phenotype or trans-differentiate into cells with an ATI-like phenotype *in vitro* ([@bib0025], [@bib0040], [@bib0230]). The goals of this study were to culture primary murine ATII cells to maintain an ATII cell phenotype or trans-differentiate into an ATI cell phenotype, then compare the susceptibility of ATI and ATII cultures to infection by respiratory viruses that cause severe disease in mice: *Influenza A virus* (PR8; family *Orthomyxoviridae*), *Murine coronavirus* (MHV-1; family *Coronaviridae*), and mouse-adapted SARS-CoV (v2163; family *Coronaviridae*). We further evaluated expression of inflammatory cytokines by ATI and ATII cultures in response to infection by these viruses. Based on their susceptibility and response to infection by respiratory viral pathogens, these cultures will be valuable in future studies to characterize the differential responses of ATI and ATII cells to viral infection and to identify the pathological mechanisms associated with viral infection in these biologically relevant cell types.

2. Materials and methods {#sec0010}
========================

2.1. Cell lines and viruses {#sec0015}
---------------------------

Vero E6 (ATCC: CRL-1586) and Madin-Darby canine kidney (MDCK; ATCC: CCL-34) cells were cultured in MEM (Invitrogen, Carlsbad, CA) containing 10% FBS (Atlanta Biologicals, Norcross, GA) and 1% antibiotic--antimycotic (Invitrogen). 17Cl-1, a spontaneously transformed clone of BALB/c 3T3 cells (provided by Dr. Kathryn Holmes, University of Colorado Denver School of Medicine), were cultured in DMEM (Invitrogen) with 10% FBS and 1% antibiotic--antimycotic ([@bib0275]). MHV-1 and IAV (A/Puerto Rico/8/1934 (H1N1)) were obtained from the American Type Culture Collection and BEI Resources, respectively. MHV-1 was propagated in 17Cl-1 cells, purified by sucrose gradient centrifugation, and titrated by plaque assay on 17Cl-1 cells, as previously described ([@bib0050], [@bib0270]). PR8 was propagated and titrated by plaque assay in MDCK cells in media containing 1% BSA and TPCK-trypsin (1 μg/ml). Mouse-adapted SARS-CoV (v2163), provided by Dr. Ralph Baric (University of North Carolina at Chapel Hill), was passaged once in Vero E6 cells before use ([@bib0030]). All experiments with v2163 were performed in a certified biosafety level 3 laboratory using protocols approved by the University of Idaho Biosafety Committee under guidelines provided in the Biosafety in Microbiological and Biomedical Laboratories, 5th Edition (Centers for Disease Control and Prevention and National Institutes of Health).

2.2. Primary cell isolation and culture {#sec0020}
---------------------------------------

Animal protocols were approved by the University of Idaho Animal Care and Use Committee according to the National Research Council Guide for the Care and Use of Laboratory Animals. Female C57BL/6 mice (8 weeks; 16--21 g) were obtained from the Center for Reproductive Biology at Washington State University (Pullman, WA). ATII cells were isolated from mice using a previously published protocol ([@bib0025]). Briefly, epithelial cells were dissociated from lung tissues by incubation in dispase (BD Biosciences, San Jose, CA), followed by mechanical disruption of the alveoli in DMEM with 0.01% DNase (Sigma--Aldrich, St. Louis, MO). The cells were filtered and incubated with biotinylated monoclonal antibodies to CD16/32 and CD45 (Southern Biotechnology, Birmingham, AL), followed by magnetic selection with Dynabeads (Invitrogen) to remove hematopoietic cells. The cells were incubated three times for 40 min at 37 °C on tissue culture treated dishes and non-adherent cells were plated as described below. Freshly isolated cells were analyzed by IFA for expression of ATII cell marker protein, LBP180, and ranged from 83 to 93% positive (Supplemental Fig. 1). To maintain an ATII cell phenotype, the ATII cells were cultured on millicell inserts (EMD Millipore Corp., Billerica, MA) coated with 70% rat tail collagen and 30% BD Matrigel (BD Biosciences), in DMEM/10% FBS supplemented with keratinocyte growth factor (KGF; 10 ng/ml; ProSpec, Rehovot, Israel) for 5 days. To promote trans-differentiation into an ATI cell phenotype, ATII cells were cultured on fibronectin (Sigma--Aldrich; 5 μg/ml) in DMEM/10% FBS for five days. The cultures were maintained at 37 °C and 10% CO~2~.

Supplementary data associated with this article can be found, in the online version, at [http://dx.doi.org/10.1016/j.virusres.2013.04.008](10.1016/j.virusres.2013.04.008){#intr0005}.

Supplementary Fig. IExpression of ATII cell marker protein, LBP180, is rapidly lost upon culture of ATII cells on fibronectin. ATII cells were cytospun onto glass slides (freshly isolated) or plated on fibronectin-coated coverslips for 16, 24, or 48 h. Expression of LBP180 was analyzed by immunofluorescence (green) and nuclei were visualized by DAPI staining (blue). Images were obtained from 7 random fields and the cells were counted to determine the percent positive for LBP180 antigen. The values to the right of each panel are the mean percentages and standard errors from these counts.

2.3. Indirect immunofluorescence assay (IFA) {#sec0025}
--------------------------------------------

The expression of ATI and ATII phenotypic markers and viral proteins was analyzed by IFA. Cells were fixed with 4% formaldehyde and permeabilized with 0.2% Triton X-100. Cellular proteins were detected with mouse monoclonal antibody to LBP180 (Abcam, Cambridge, MA) or Syrian hamster anti-T1α (provided by Dr. Maria Ramirez, Boston University School of Medicine) and secondary antibodies: goat anti-mouse-488 (Invitrogen) or rabbit anti-hamster-FITC (Abcam), respectively. v2163 infection was detected using monoclonal antibody NR-619, which recognizes the nucleocapsid protein of SARS-CoV (BEI Resources) and anti-mouse IgM-TRITC (Millipore). Surface expression of ACE2 and TMPRSS2 was evaluated on non-permeabilized cells using rabbit primary antibodies (Abcam) and anti-rabbit-488 (Invitrogen). MHV-1 infection was evaluated using a monoclonal antibody that recognizes the nucleocapsid protein of MHV-1 (provided by Dr. Julian Leibowitz, Texas A&M University), followed by goat anti-mouse-488 (Invitrogen). Goat antiserum NR-3148, which recognizes the hemagglutinin protein of PR8 (BEI Resources), and anti-goat-555 (Invitrogen) were used to detect PR8 infection. Cells were stained with DAPI to visualize nuclei and were photographed on a Nikon Eclipse Epifluorescent Microscope with a Hamamatsu digital camera and MetaMorph software (Molecular Devices).

2.4. Western blot analysis {#sec0030}
--------------------------

Cells were lysed in RIPA buffer and equal amounts of cell protein, as determined by BCA Protein Assay (Thermo Fisher Scientific, Rockford, IL), were resolved by SDS-PAGE under reducing conditions and transferred to Immobilon PVDF membranes (Millipore). Membranes were incubated with primary antibody to T1α, followed by HRP-conjugated anti-hamster antibody (Abcam), which was detected by chemiluminescence. Protein loading was evaluated using an antibody to β-actin (Abcam).

2.5. Cytokine gene expression analysis {#sec0035}
--------------------------------------

Total cellular RNA was isolated using Trizol Reagent, according to the manufacturer\'s recommendations (Invitrogen). Mouse Inflammatory Cytokines and Receptors RT^2^ Profiler PCR Arrays were used to quantify the expression of 84 inflammatory genes in IAV-, MHV-1-, and mock-inoculated ATI-like cells (SABiosciences/QIAGEN, Valencia, CA). Where indicated, lipopolysaccharide (LPS; Sigma--Aldrich; 1 μg/ml) was used to induce cytokine expression. Expression of IL-1β was quantified in mock-inoculated and virus-infected ATI-like and ATII cells by qPCR using published primer sequences ([@bib0205]) and SYBR green in a StepOnePlus instrument (Applied Biosystems, Carlsbad, CA). Expression of β-actin was quantified to determine relative expression levels, using primers: 5′-AAGTCCCCTCACCCTCCCAAAAG and 5′-AAGCAATGCTGTCACCTTCCC. Relative expression was determined by the reciprocal of the ΔCt (1/Ct\[IL-1β\] − Ct\[β-actin\]). Means and standard errors from at least three experiments were used to test for statistical significance compared to expression in mock-treated cells using an unpaired *t* test and *p*  \< 0.05 was determined to be significant.

3. Results {#sec0040}
==========

3.1. Phenotypes of primary alveolar epithelial cells {#sec0045}
----------------------------------------------------

Both ATI and ATII cells are infected by IAV and SARS-CoV *in vivo*, in fatal human cases and mouse models ([@bib0110], [@bib0200], [@bib0235], [@bib0255], [@bib0250], [@bib0285]). In order to study viral infection of these highly specialized cell types *in vitro*, we evaluated culture conditions to maintain the phenotype of primary murine ATII cells, or to acquire an ATI cell phenotype. Expression of lamellar body protein 180 (LBP180/ABCA3) was evaluated to identify differentiated ATII cells ([@bib0190], [@bib0320]). T1α is a marker of differentiated ATI cells that is not expressed by ATII cells, and was used to monitor expression of an ATI-like phenotype ([@bib0045], [@bib0220]). When cultured *in vitro*, ATII cells readily lose expression of ATII-specific proteins and gain expression of ATI-specific proteins, suggesting trans-differentiation to an ATI cell phenotype ([@bib0040], [@bib0145], [@bib0165]). Furthermore, the loss of ATII-specific markers coincides with changes in morphology and the disappearance of lamellar bodies and surfactant production ([@bib0210], [@bib0320]). Freshly isolated ATII cells were analyzed for LBP180 expression by IFA and random fields were counted to estimate the percentage of positive cells. Approximately 90% of freshly isolated cells expressed the ATII-specific protein, LBP180 (Supplemental Fig. 1). The percentage of cells expressing LBP180 rapidly decreased during culture on fibronectin-coated coverslips, to approximately 62% positive by day 2 after isolation (Supplemental Fig. 1 and [Fig. 1](#fig0005){ref-type="fig"}A). Further culture of murine ATII cells on fibronectin resulted in significantly reduced expression of LBP180 by day 4 after isolation and LBP180 was not detected on day 7 ([Fig. 1](#fig0005){ref-type="fig"}A, left panels). Under these same culture conditions, the expression of T1α (ATI-specific) was increased by day 4 after isolation, which increased further by day 7 ([Fig. 1](#fig0005){ref-type="fig"}A and B). Thus, concomitant with the loss of LBP180 expression, these primary cultures acquired expression of T1α, suggesting a transition from a predominantly ATII to ATI-like phenotype.Fig. 1Trans-differentiation of murine ATII cells to an ATI-like cell phenotype. (A) ATII cells were cultured on fibronectin-coated coverslips for the indicated times and immunofluorescence assay was used to detect expression of phenotypic marker proteins of ATII cells, LBP180, or ATI cells, T1α. Nuclei were stained with DAPI, inset panels. (B) ATII cells were lysed on the day of isolation (day 0) or cultured on fibronectin and lysed on the indicated days. Cell lysates were analyzed by Western blot analysis using antibody against T1α or β-actin, as a protein loading control. The images shown are representative of three replicate experiments.

In order to promote expansion of the ATII cells while maintaining their phenotype, we plated the cells on 70% rat tail collagen and 30% Matrigel (CM matrix) and provided KGF in the growth medium. ATII cells cultured on CM matrix with KGF maintained expression of LBP180 through 7 days after isolation, with maximal expression on day 5 ([Fig. 2](#fig0010){ref-type="fig"}A, right panels). Exclusion of KGF from the medium resulted in significantly fewer LBP180-expressing cells on days 5 and 7 after isolation ([Fig. 2](#fig0010){ref-type="fig"}A, left panels). Furthermore, ATII cells cultured on CM matrix with KGF did not express an ATI cell-specific protein, T1α, in comparison to trans-differentiated ATI-like cells cultured on fibronectin ([Fig. 2](#fig0010){ref-type="fig"}B). ATII cells cultured on matrices with an increased proportion of collagen to matrigel (80:20), had reduced expression of LBP180 (Data not shown). Thus, murine ATII cells maintained expression of LBP180 for short time periods (2 days) of culture on fibronectin alone and for longer time periods (5--7 days) when cultured on 70:30 CM matrix with KGF.Fig. 2Maintenance of ATII cell phenotype in cultured murine cells. ATII cells were cultured on 70% collagen/30% matrigel (CM) matrix for 5 or 7 days with or without keratinocyte growth factor (KGF) in the medium. Immunofluorescence assay was used to detect the expression of (A) ATII marker protein, LBP180, or (B) ATI marker protein, T1α. Cells cultured on fibronectin were used as a positive control for T1α expression.

3.2. Mouse-adapted SARS-CoV, v2163, infects murine cultures with an ATII, but not ATI, cell phenotype {#sec0050}
-----------------------------------------------------------------------------------------------------

SARS-CoV RNA and antigens were detected in both ATI and ATII cells in lung tissues from fatal SARS cases ([@bib0200]). Human isolates of SARS-CoV do not cause lethal disease in mice, but acquire virulence upon serial passage in mice ([@bib0030], [@bib0235]). These mouse-adapted isolates are used to study the mechanisms of SARS-CoV pathogenesis *in vivo* ([@bib0055]). v2163 is an isolate of SARS-CoV that was passaged 25 times in the lungs of BALB/c mice and causes a highly lethal pulmonary infection in mice ([@bib0030]). We tested murine pneumocytes with either an ATI or ATII cell phenotype for susceptibility to infection by v2163. Cultures with an ATI cell phenotype rarely showed cells with viral antigen 24 h post-inoculation (p.i.), and no viral antigen was detected by 48 h p.i. ([Fig. 3](#fig0015){ref-type="fig"}A, bottom panels). In contrast, viral antigen was detected at both 24 and 48 h p.i. in cells cultured with an ATII phenotype ([Fig. 3](#fig0015){ref-type="fig"}A, top panels). Thus, mouse-adapted SARS-CoV preferentially infected alveolar epithelial cells with an ATII cell phenotype *in vitro*.Fig. 3Susceptibility of primary murine alveolar epithelial cells to infection by mouse-adapted SARS-CoV. (A) Murine cells were cultured as either an ATI or ATII cell phenotype for 5 days, then were inoculated with mouse-adapted SARS-CoV, isolate v2163 for 24 or 48 h. Infection was analyzed by immunofluorescence assay of viral nucleocapsid protein (red) and nuclei were stained with DAPI (blue). (B) Cells cultured for 5 days with an ATI cell phenotype were analyzed by immunofluorescence using rabbit antibodies against ACE2 or TMPRSS2 (green) and nuclei were stained with DAPI (blue). A fluorescently labeled antibody against rabbit IgG was used as a negative control.

In order to determine if the lack of SARS-CoV receptor expression by ATI-like cells was responsible for them being refractory to v2163 infection, we evaluated expression of murine ACE2 by IFA on non-permeabilized ATI-like cells. ATI-like cells that were evaluated for ACE2 expression on day 5 after isolation, the same day cells were inoculated with v2163, had robust expression of ACE2 on the cell surface ([Fig. 3](#fig0015){ref-type="fig"}B). In addition, these cells were evaluated for expression of TMPRSS2, a serine protease that interacts with ACE2 and enhances infection of cells by SARS-CoV ([@bib0260]). The ATI-like cells also had robust surface expression of TMPRSS2 on day 5 after isolation ([Fig. 3](#fig0015){ref-type="fig"}B). Thus, expression of ACE2 and TMPRSS2 does not correspond with the susceptibility of murine alveolar epithelial cells to infection by v2163.

3.3. MHV-1 replicates in primary murine cultures with an ATI or ATII cell phenotype {#sec0055}
-----------------------------------------------------------------------------------

MHV-1 is a murine coronavirus that causes severe disease and pathology in the lungs of specific genetic lines of mice ([@bib0035], [@bib0100]). The pathology of MHV-1 infection in A/J mice resembles that seen in fatal SARS cases, thus MHV-1 is studied as a model of SARS pulmonary pathogenesis ([@bib0035]). ATI-like cells were inoculated with MHV-1 and monitored for cytopathic effects (CPE), the presence of viral antigen, and production of infectious virus over time. MHV-1 infection of ATI-like cells resulted in the formation of syncytia and rounding up of cells in the monolayer by 24 h p.i. ([Fig. 4](#fig0020){ref-type="fig"}A, top panels, and [4](#fig0020){ref-type="fig"}B). Viral nucleocapsid protein antigen was detected in approximately 50% of the cells by 12 h p.i., and expanded to the majority of cells in the culture by 24 h p.i. ([Fig. 4](#fig0020){ref-type="fig"}A, top panels). The presence of viral antigen corresponded to increased release of infectious virus through 24 h p.i. ([Fig. 4](#fig0020){ref-type="fig"}C).Fig. 4Susceptibility of primary murine alveolar epithelial cells to infection by murine coronavirus, MHV-1. (A) Murine cells were cultured as either an ATI or ATII cell phenotype for 5 days, then were inoculated with MHV-1 for 12 or 24 h. Infection was analyzed by immunofluorescence assay of viral nucleocapsid protein (green) and nuclei were stained with DAPI (blue). (B) Cells were cultured on fibronectin (ATI phenotype) and inoculated with MHV-1 or mock-inoculated. Cells were photographed on phase contrast at 24 h p.i. (C) Infection of MHV-1-inoculated ATI and ATII cells was analyzed by plaque assay of supernatant medium at the indicated times. The mean virus titers and standard errors from four replicate experiments are shown.

ATII cultures were also tested for susceptibility to infection by MHV-1. In agreement with infection of ATI-like cells, viral antigen was detected in ATII cells at 12 and 24 h p.i., and the titer of infectious virus in the medium increased over a similar time course ([Fig. 4](#fig0020){ref-type="fig"}A, bottom panels and [4](#fig0020){ref-type="fig"}C). In contrast to infection of ATI-like cells, MHV-1 did not induce syncytia formation or visible CPE in ATII cell cultures. Despite a lower proportion of viral antigen-expressing cells, cultures with an ATII phenotype produced higher titers of virus through 24 h p.i. ([Fig. 4](#fig0020){ref-type="fig"}C). Syncytia formation and cell death seen in the ATI-like cells may limit the production of MHV-1 compared to infection in ATII cultures. These results show that MHV-1 established a productive infection in cultures with either ATI or ATII cell phenotypes, which differed in CPE and virus production.

3.4. PR8 replicates in primary murine cultures with an ATI or ATII cell phenotype {#sec0060}
---------------------------------------------------------------------------------

The PR8 strain of influenza A virus is frequently used as a model for viral pneumonia, and the spread of PR8 to the alveoli in infected mice corresponds with increased disease severity ([@bib0020], [@bib0090]). To determine whether primary murine cells with an ATI or ATII cell phenotype are susceptible to PR8 infection *in vitro*, primary cultures were inoculated with PR8 and infection was analyzed by IFA and plaque assay. Like murine coronavirus, MHV-1, PR8 infected primary cultures with both ATI and ATII cell phenotypes ([Fig. 5](#fig0025){ref-type="fig"} ). However, the kinetics of infection was slower, with the peak of viral antigen expressing cells present at 48 h p.i. Although CPE were not apparent, reduced viral antigen expression late in infection (72 h p.i.) suggests a decline in the number of susceptible cells in the culture. The viral growth curves for PR8 replication in ATI and ATII cells were indistinguishable ([Fig. 5](#fig0025){ref-type="fig"}C).Fig. 5Susceptibility of primary murine alveolar epithelial cells to infection by influenza A virus, PR8. (A) Murine cells were cultured as either an ATI or ATII cell phenotype for 5 days, then were inoculated with PR8. Infection was analyzed by immunofluorescence assay of viral hemagglutinin protein (red) and nuclei were stained with DAPI (blue) at the indicated times post infection (p.i.). (B) Co-localization of ATI (T1α) or ATII (LBP180) phenotypic proteins (green) and PR8 antigen (red) was analyzed by dual IFA 24 h p.i. Nuclei were stained with DAPI (blue). (C) Infection of PR8-inoculated ATI and ATII cells was analyzed by plaque assay of supernatant medium at the indicated times. The mean virus titers and standard errors from five replicates are shown.

In both ATI and ATII cultures, a lower proportion of cells were infected by PR8 compared to MHV-1. As our phenotypic analysis of these cultures demonstrated heterogeneity in expression of ATI and ATII marker proteins ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}), we next determined whether PR8 infects differentiated cells or other cells within these cultures. Co-localization of viral antigen and T1α (ATI-specific protein) was evaluated in ATI cultures 24 h after inoculation with PR8 by dual IFA. A majority of cells that contained PR8 antigen were also positive for T1α expression, which demonstrated that PR8 infects cells with an ATI cell phenotype ([Fig. 5](#fig0025){ref-type="fig"}B, top panels). However, many T1α positive cells were not infected by PR8. Similarly, in cells cultured with an ATII phenotype, PR8 antigens were detected in cells expressing ATII phenotypic marker, LBP180 ([Fig. 5](#fig0025){ref-type="fig"}B, bottom panels). However, PR8 infection was not exclusively found in LBP180-positive cells. A majority of ATII cells plated on fibronectin remained LBP180 positive by day 2 after isolation (Supplemental Fig. 1). Therefore, we inoculated ATII cells with PR8 one day after isolation and performed dual IFA for LBP180 and PR8 antigens 24 h p.i. (Supplemental Fig. 2). As with our ATII cells plated on CM matrix, some but not all LBP180 positive cells were also positive for PR8 antigens. Taken together, these experiments demonstrate that PR8 does infect alveolar cells expressing ATI or ATII specific proteins.

Supplementary data associated with this article can be found, in the online version, at [http://dx.doi.org/10.1016/j.virusres.2013.04.008](10.1016/j.virusres.2013.04.008){#intr0010}.

Supplementary Fig. IICo-localization of PR8 and LBP180 antigens in ATII cells infected on day 1 after isolation. Murine ATII cells were plated on fibronectin-coated coverslips overnight, then inoculated with PR8. Expression of viral antigen (red) and ATII cell phenotypic marker LBP180 (green), were analyzed by IFA 24 h p.i. The two rows of images are from two independent experiments.

3.5. Cytokine gene expression in virus-infected alveolar epithelial cells {#sec0065}
-------------------------------------------------------------------------

Alveolar epithelial cells express cytokines and chemokines in response to viral infection, thereby contributing to the influx of inflammatory cells into the lungs. We evaluated the response of ATI-like cells to infection by MHV-1 and PR8 using RT-PCR arrays that quantify RNA for 84 cytokines. Compared to mock-inoculated cells, PR8 and MHV-1 induced mRNA expression of a shared group of cytokines (IL-10, IL-16, IL-1β, IL-36α, TNF-α, LT-α, LT-β), chemokines (CCL2, 4, 7, 8, CXCL1, 10, 14), and receptors (CCR3, TNFRII) ([Table 1](#tbl0005){ref-type="table"} ). In addition to these shared cytokines, MHV-1 induced expression of several additional genes that were not induced by PR8 infection in ATI-like cells (Supplemental Table 1). In contrast, only three chemokine genes (CCL5, CCL9, and CXCL11) were differentially expressed by PR8-infected cells.Table 1Cytokine gene expression in ATI-like cells infected by IAV and MHV-1.[a](#tblfn0005){ref-type="table-fn"}GeneFold change vs. mock[b](#tblfn0010){ref-type="table-fn"}IAVMHV-1Bcl62.84.0Ccl22.23.2Ccl203.111.1Ccl42.12.0Ccl72.23.0Ccl82.62.3Ccr33.23.8Cxcl15.011.5Cxcl108.05.2Cxcl135.62.1Il102.410.7Il162.85.8Il1b2.110.3Il1f63.03.7Lta2.65.6Ltb2.325.2Tnf9.16.0Tnfrsf1b2.75.2[^1][^2]

Supplementary data associated with this article can be found, in the online version, at [http://dx.doi.org/10.1016/j.virusres.2013.04.008](10.1016/j.virusres.2013.04.008){#intr0015}.

Table S1Cytokine gene expression in ATI-like cells infected by IAV and MHV-1.^a^

As a canonical pro-inflammatory cytokine that contributes to the local recruitment and activation of inflammatory cells in addition to systemic symptoms of viral infection, the production of IL-1β has important consequences for both viral clearance and disease severity. Expression of IL-1β mRNA was quantified by qRT-PCR in ATI-like cells infected by MHV-1 or PR8 at 6 and 24 h p.i. ([Fig. 6](#fig0030){ref-type="fig"}A), and in ATII cells infected by PR8, MHV-1, or v2163 at 24 h p.i. ([Fig. 6](#fig0030){ref-type="fig"}B). LPS was used as a positive control to induce IL-1β expression in both cell types. Expression of IL-1β was induced significantly by PR8 and MHV-1 infection of ATI-like cells by 24 h p.i. ([Fig. 6](#fig0030){ref-type="fig"}A). MHV-1 infection stimulated a similar increase in IL-1β expression in both ATI-like and ATII cells ([Fig. 6](#fig0030){ref-type="fig"}A and B), however PR8 infection in ATII cells stimulated a lower level of IL-1β expression, which did not reach statistical significance ([Fig. 6](#fig0030){ref-type="fig"}B). Infection of ATII cells by v2163 also resulted in increased IL-1β expression ([Fig. 6](#fig0030){ref-type="fig"}B). Interestingly, while both ATI-like and ATII cells expressed IL-1β in response to LPS, expression in ATI-like cells was induced to a higher level. These results show that primary murine alveolar epithelial cells respond differently to viral infection and LPS stimulation under culture conditions that generate an ATI-like or ATII phenotype.Fig. 6Expression of IL-1β by primary murine alveolar epithelial cells in response to respiratory viral infection. Murine cells were cultured as an ATI (A) or ATII (B) cell phenotype, infected by the indicated viruses, and IL-1β mRNA was quantified by RT-qPCR. All ATII cell samples (B) were infected for 24 h. Mock-inoculated and LPS-treated cells were used as negative and positive controls, respectively. Expression of IL-1β was normalized to that of β-actin and the means and standard errors from 3 to 5 replicate experiments are shown. Statistically significant differences in expression compared to mock samples were determined by unpaired *t* test. \**p* \< 0.05, \*\**p* \< 0.005.

4. Discussion {#sec0070}
=============

Due to its critical function in respiration, damage to the alveolar epithelium by viral infection results in severe, potentially fatal, disease. In order to design novel therapies that successfully limit this damage, it is imperative that we identify the mechanisms that contribute to lung pathology during infection of alveolar epithelial cells. The response of alveolar epithelial cells to viral infection has been studied in a variety of models, including continuous cell lines and primary cell cultures. Continuous cell lines, such as A549 that are used as a model of ATII cells, have key biochemical and structural differences compared to their *in vivo* counterparts ([@bib0155], [@bib0280]). These differences limit the usefulness of continuous lines in identifying physiologically relevant mechanisms of viral pathogenesis. Primary alveolar epithelial cells isolated from human lung tissues have been used to study respiratory viral pathogenesis in differentiated cell types *in vitro* ([@bib0115], [@bib0185], [@bib0305], [@bib0300]). However, access to human lung tissues and genetic variability are factors that limit their usefulness for mechanistic studies. Primary rat alveolar epithelial cells cultured with distinct ATI and ATII phenotypes have been widely used as *in vitro* models for studies of lung physiology ([@bib0075], [@bib0215]). Limitations of rat model systems include the very few genetic knock-out lines and established models of respiratory viral infections ([@bib0065], [@bib0180], [@bib0240]). Based on the availability of well-characterized genetic lines and established models of respiratory viral pathogenesis, it is highly desirable to establish murine ATI and ATII cell models to study virus--host interactions in the differentiated cell types of the alveolar epithelium. Other researchers have optimized the isolation and culture of differentiated ATII cells from mice and established culture conditions to maintain their ATII phenotype or trans-differentiate into cells with the morphological and functional characteristics of ATI cells ([@bib0025], [@bib0085], [@bib0170], [@bib0230]). Murine ATI-like cells that were derived from isolated ATII cells have been used to study influenza virus infection *in vitro* ([@bib0085], [@bib0080], [@bib0285]). In the present study, primary murine alveolar cells were cultured with ATI or ATII cell phenotypes and their susceptibility and inflammatory response to infection by respiratory viruses were compared. This *in vitro* system will be invaluable in future studies to identify the mechanisms of pathogenesis during viral infection of the alveolar epithelium that can be directly compared to robust murine models of viral pathogenesis *in vivo*.

Serial passage of the Urbani strain of SARS-CoV in the lungs of mice resulted in enhanced virulence of the virus in mice and thus provides an animal model that replicates the disease pathogenesis observed in human patients ([@bib0030], [@bib0235]). The v2163 strain, which is the result of 25 passages in the lungs of BALB/c mice, causes dose-dependent lethality in young (5--6 weeks old) mice ([@bib0030]). During serial passage, v2163 acquired four mutations that result in amino acid changes in the spike glycoprotein. Two of these changes are in residues of the receptor binding motif that interacts with ACE2 and, as predicted by structural modeling, may enhance binding to murine ACE2 ([@bib0030], [@bib0055]). Adaptation of the spike glycoprotein to bind more efficiently to ACE2 proteins of different species is thought to be critical for changes in the host range and tissue tropism of SARS-CoV ([@bib0010], [@bib0055], [@bib0130], [@bib0245]). We observed that primary murine ATI-like cells were not susceptible to infection by v2163, so ACE2 expression by these cells was evaluated. ATI-like cells had robust surface expression of ACE2, suggesting that ACE2 binding is not the limiting factor in susceptibility to v2163 infection. Other groups have recently demonstrated the importance of a cellular protease, TMPRSS2, in enhancing ACE2-dependent and -independent infection by SARS-CoV ([@bib0070], [@bib0160], [@bib0260]). It is not known whether TMPRSS2 is important for infection by mouse-adapted strains of SARS-CoV. Regardless, we detected high levels of TMPRSS2 on the surface of murine ATI-like cells. The mechanism(s) that restricts replication of v2163 in murine ATI-like cells is not known, but our study suggests that expression of murine ACE2 and TMPRSS2 are not limiting factors. Like our study, Mossel et al. found human primary ATI-like cells to be refractory to SARS-CoV infection *in vitro* ([@bib0185]). However, they observed that SARS-CoV infection of primary cells corresponded with the level of ACE2 expressed by the cells.

In addition to mouse-adapted SARS-CoV, we evaluated the susceptibility of murine ATI-like and ATII cells for infection by a murine coronavirus, MHV-1. MHV-1 infects the respiratory tract and causes disease with a wide range of severities, depending upon the genetic line of mice ([@bib0035], [@bib0100]). Upon intranasal inoculation with MHV-1, BALB/cJ mice exhibit some of the pathological characteristics of SARS in humans, including pulmonary congestion, alveolar and interstitial inflammation, and hyaline membranes. However, MHV-1 infection is not lethal in BALB/cJ mice, which show only mild clinical signs of disease and recover completely. In contrast, infection of A/J mice with MHV-1 results in severe lung pathology and death of infected mice. The lung pathology seen in MHV-1 infected A/J mice is similar to fatal SARS cases in humans, including severe edema, thickening of the alveolar epithelium, interstitial inflammation, fibrin deposits, and hyaline membranes. Although MHV-1 virions have been detected by electron microscopy in alveolar macrophages late during infection of A/J mice, infection of pneumocytes early during infection cannot be excluded. Furthermore, ATI cells express fibroleukin during MHV-1 infection of A/J mice, suggesting a role for these cells in fibrin deposition in the alveoli ([@bib0035]). Primary murine ATI-like cells provide an attractive model for studying the signaling pathways involved in MHV-1-induced fibroleukin expression and their potential role in fibrin deposition during viral infection in the lung. The mechanisms responsible for the differential pathogenesis seen during respiratory infection of various mouse strains by MHV-1 have not been determined. Future studies using primary alveolar epithelial cells from different genetic lines of mice will determine the potential contributions of these cell types to pathogenic outcomes of infection.

The pulmonary pathology in fatal cases of influenza viral pneumonia is characterized by diffuse alveolar damage, including the presence of hyaline membranes, inflammatory cells, and edema in the alveoli ([@bib0135], [@bib0195], [@bib0250]). The mouse-adapted PR8 strain of influenza A virus has been widely studied as a model for influenza pneumonia because it induces similar pathology in specific inbred strains of mice ([@bib0020], [@bib0060]). The virulence of different PR8 variants in various murine genetic lines is correlated with increased viral replication and spread to the alveolar regions of the lung ([@bib0020]). Infection of the alveoli by PR8 results in dramatic pathology associated with inflammation, leukocytic infiltration, and destruction of the epithelial surface ([@bib0020], [@bib0060], [@bib0140]). Epithelial damage is likely due to a combination of direct viral cytopathic effects and the inflammatory response. Inhibition of inflammatory mediators during influenza virus infection in mice lessens morbidity and mortality, suggesting that the inflammatory response is a critical determinant of severe disease outcomes ([@bib0080], [@bib0120], [@bib0295]). Herold et al. further demonstrated that macrophages recruited to the lungs during PR8 infection in mice have a direct role in alveolar damage by inducing apoptosis of ATI cells ([@bib0080]). Murine ATII cells cultured to acquire an ATI cell phenotype *in vitro* have been used to study influenza virus infection in the alveolar epithelium and how infected ATI cells interact with monocytes to mediate disease pathology ([@bib0085], [@bib0080]). Our study confirmed results of previous studies demonstrating susceptibility of and cytokine expression by murine alveolar epithelial cells in response to PR8 infection ([@bib0085], [@bib0285]). We also established the susceptibility of primary murine cells with an ATII phenotype to PR8 infection. While infection of ATI and ATII cultures by PR8 was not as robust as MHV-1, a significant amount of infectious PR8 was released from these cultures. We further demonstrated that PR8 infection co-localized with ATI and ATII phenotypic markers, suggesting infection of these cell types. However, in ATII cell cultures, PR8 antigens were also detected in LBP180-negative cells. While the exact nature of these cells is not known, many possibilities exist. Our ATII cell isolations ranged from 83 to 93% LBP180-positive, which is similar to the purity reported by others ([@bib0025], [@bib0170]). Thus, the LBP180-negative cells could be contaminating cell types from the isolation procedure, including fibroblasts, endothelial cells, or white blood cells. Furthermore, ATII cells can trans-differentiate into ATI-like cells or undergo epithelial to mesenchymal transition when cultured *in vitro* ([@bib0105]). The LBP180-negative cells in our cultures may be ATII cells that are no longer fully differentiated. However, our dual antigen labeling demonstrated that alveolar cells with either ATI or ATII phenotype can be infected by PR8. As ATI and ATII cells are both targeted in severe influenza virus infections, it is important to identify the responses of these unique cell types to infection. In addition to inflammation-induced damage, electron microscopy has demonstrated budding of PR8 virions from ATI and ATII cells early during infection with extensive damage to the epithelial surface over time ([@bib0140]). Differentiated cultures of alveolar epithelial cells will be critical for identifying the mechanisms responsible for direct viral damage to the alveolar epithelium during infection.

The pathogenesis of respiratory viral infections is often correlated with an excessive inflammatory response in the lungs. Alveolar epithelial cells express proinflammatory cytokines and chemokines in response to viral infection and may be important in the initiation of these damaging inflammatory responses ([@bib0085], [@bib0180], [@bib0240], [@bib0285], [@bib0300]). In this study, we compared cytokine expression by murine ATI-like cells infected by MHV-1 or PR8, and IL-1β expression by ATI-like and ATII cells infected by MHV-1, PR8, or v2163. Infection of ATI-like cells by MHV-1 or PR8 induced similar cytokine profiles, which correspond to cytokine expression in the lungs of infected mice ([@bib0005], [@bib0125], [@bib0265]). Interestingly, MHV-1 also stimulated expression of several cytokines and chemokines that were not expressed upon PR8 infection. It is not known whether this difference has biological relevance during *in vivo* infection. The inflammatory response to MHV-1 has been characterized in A/J mice, which have severe disease outcomes to infection ([@bib0035]). Our primary cells were isolated from C57Bl/6 mice, which have mild infection in the respiratory tract by MHV-1 ([@bib0035]). The mechanisms that underlie the differences in pathogenesis of MHV-1 infection in different genetic lines of mice have not been clearly defined. In general, increased cytokine expression correlates with disease severity in both MHV-1 and PR8 infection models. Thus, it will be important to identify the mechanisms whereby alveolar epithelial cells detect viral infection and determine their role in the detrimental inflammatory response to viral infection in the lung. ATI and ATII cells are both targets for viral infection within the alveoli. In this study, we directly compared expression of IL-1β by murine ATI-like and ATII cells in response to viral infection. IL-1β expression was induced by LPS to a high level in ATI-like, but only moderately in ATII cells. Raoust et al. also observed cytokine expression by primary murine cells cultured with an ATI cell phenotype upon treatment with LPS ([@bib0225]). A recent study demonstrated that murine ATII cells cultured similarly to those in our study express chemokines CCL2 and CXCL2 in response to LPS treatment, suggesting that these cells are capable of LPS-induced responses through TLR4 signaling ([@bib0015]). Infection by PR8 and MHV-1 induced IL-1β expression by 24 h p.i. in ATI-like cells. Viral infection induced expression of IL-1β in ATII cells, yet similar to LPS, expression was not as robust as in ATI cells. Thus, ATI-like and ATII cells responded differently to the same viral infections, and the level of IL-1β expression was dependent both on the cell phenotype and the specific virus. Other studies have reported differential expression of cytokines by primary alveolar epithelial cells cultured with an ATI-like or ATII cell phenotype ([@bib0175], [@bib0315]). Human primary alveolar epithelial cells cultured with an ATI-like or ATII phenotype express very similar levels of cytokine mRNA upon infection by influenza viruses ([@bib0315]). Despite similarities in mRNA levels, secretion of MCP-1 is dramatically increased upon influenza virus infection of ATI-like, but not ATII, cells ([@bib0315]). A similar finding between our study and others is the observation that despite having a similar susceptibility to viral infection, cultures with ATI and ATII phenotypes can have different responses to these infections. Determining the mechanisms whereby ATI and ATII cells detect viral infections and regulate cytokine expression in the lungs is a critical next step of these studies. Primary murine alveolar epithelial cells will be crucial in the identification of these mechanisms.
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[^1]: RNA was extracted from IAV or MHV-1 infected ATI-like cells 24 h p.i. and mRNA for inflammatory cytokines and receptors was quantified by qPCR Array (SABiosciences). Genes included are those with at least a two fold increase compared to mock-inoculated cells in at least two replicate experiments.

[^2]: Fold change values are representative values from three (IAV) or two (MHV-1) replicate samples.
